نتایج جستجو برای: antifungals

تعداد نتایج: 1520  

2014
Rajamani Lakshminarayanan Radhakrishnan Sridhar Xian Jun Loh Muruganantham Nandhakumar Veluchamy Amutha Barathi Madhaiyan Kalaipriya Jia Lin Kwan Shou Ping Liu Roger Wilmer Beuerman Seeram Ramakrishna

Topical application of antifungals does not have predictable or well-controlled release characteristics and requires reapplication to achieve therapeutic local concentration in a reasonable time period. In this article, the efficacy of five different US Food and Drug Administration-approved antifungal-loaded (amphotericin B, natamycin, terbinafine, fluconazole, and itraconazole) electrospun gel...

2016
Andrew G. S. Warrilow Claire L. Price Josie E. Parker Nicola J. Rolley Christopher J. Smyrniotis David D. Hughes Vera Thoss W. David Nes Diane E. Kelly Theodore R. Holman Steven L. Kelly

Malassezia globosa cytochromes P450 CYP51 and CYP5218 are sterol 14α-demethylase (the target of azole antifungals) and a putative fatty acid metabolism protein (and a potential azole drug target), respectively. Lanosterol, eburicol and obtusifoliol bound to CYP51 with Kd values of 32, 23 and 28 μM, respectively, catalyzing sterol 14α-demethylation with respective turnover numbers of 1.7 min(-1)...

Journal: :Journal of cutaneous medicine and surgery 2015
Aditya K Gupta R Gary Sibbald Anneke Andriessen Richard Belley Alan Boroditsky Mariam Botros Robert Chelin Wayne Gulliver David Keast Mani Raman

BACKGROUND Onychomycosis is a difficult-to-treat infection whose current treatment paradigm relies primarily on oral antifungals. The emergence of new topical drugs broadens the therapeutic options and prompts a re-evaluation of the current Canadian treatment strategy. OBJECTIVE To define a patient-centred Canadian treatment strategy for onychomycosis. METHODS An expert panel of doctors who...

Journal: :Chest 2003
David R Snydman

The incidence of candidemia--a common and potentially fatal nosocomial infection--has risen dramatically, and this increase has been accompanied by a shift in the infecting pathogen away from Candida albicans to treatment-resistant non-albicans species. Prophylactic azole antifungals, such as fluconazole, may play an important role not only in the management of candidemia but also in the prolif...

Journal: :Clinical Microbiology and Infection 2003

2003
Deepti Dwivedi B. N. Johri

CURRENT SCIENCE, VOL. 85, NO. 12, 25 DECEMBER 2003 1693 *For correspondence. (e-mail: [email protected]) 64. Iso, M., Chen, B., Eguchi, M., Kudo, T. and Shreshtha, S., Production of biodiesel fuel from triglycerides and alcohol using immobilized lipase. J. Mol. Catal. B, Enzymes, 2001, 16, 53–58. 65. Nakanishi, K. and Matsuno, R., Continuous peptide synthesis in a water-immiscible o...

Journal: :Blood 2004
Kieren A Marr Wendy Leisenring Fulvio Crippa John T Slattery Lawrence Corey Michael Boeckh George B McDonald

We performed a randomized trial to compare the safety and efficacy of itraconazole with fluconazole in preventing fungal infections in patients undergoing allogeneic stem cell transplantation (SCT). Itraconazole (intravenous 200 mg daily, or oral solution 2.5 mg/kg 3 times daily) and fluconazole (intravenous or oral, 400 mg daily) were administered with the start of conditioning therapy, until ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید